# Distribution of ABO and D antigen expression in Yogyakarta, Java Island: a pioneer large-scale study in Indonesia

Hasna Fadlilatul Bidayah, Teguh Triyono, Yann Fichou, Rarastoeti Pratiwi, Diah Nurpratami, Abdul Salam Sofro

<figure><img src="image_1.png" /></figure>

► To cite this version:

Hasna Fadlilatul Bidayah, Teguh Triyono, Yann Fichou, Rarastoeti Pratiwi, Diah Nurpratami, et al. Distribution of ABO and D antigen expression in Yogyakarta, Java Island: a pioneer large-scale study in Indonesia. BMC Research Notes, 2024, 17 (1), pp.273. 10.1186/s13104-024-06914-5. [https://hal.science/hal-05037904v1](https://hal.science/hal-05037904v1) [hal-05037904]

HAL Id: hal-05037904

https://hal.science/hal-05037904v1

Submitted on 17 Apr 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_2.png" /></figure>
RESEARCH NOTE

Open Access

<figure><img src="image_3.png" /></figure>

Check for
updates

# Distribution of ABO and D antigen expression in Yogyakarta, Java Island: a pioneer large-scale study in Indonesia

Hasna Fadlilatul Bidayah¹, Teguh Triyono<fnref n="2" />,<fnref n="3" />*, Yann Fichou<fnref n="4" />,<fnref n="5" />, Rarastoeti Pratiwi¹,<fnref n="6" />, Diah Nurpratami<fnref n="7" />,<fnref n="8" /> and Abdul Salam Sofro¹

**Abstract**

**Objective** Here, we sought to report ABO and D antigen distribution in blood donors from Yogyakarta, Java Island, Indonesia. Phenotype data (ABO/D) from donors who donated blood between January 1, 2018, and December 31, 2023, at the Yogyakarta Blood Donor Unit were extracted from the blood donor registry, and phenotype frequency was calculated subsequently.

**Results** In the 245,307 blood donors collected over six years, ABO phenotype frequency: O (frequency: 38.5%) > B (29.4%) > A (24.1%) > AB (8.0%). The D-positive phenotype was far more common (99.5%) than the D-negative phenotype (0.5%). The phenotypic pattern globally is similar to previous reports in Southeast Asia. The D antigen distribution is similar to world distribution as the most common blood group. For the first time in Indonesia, this distribution of ABO and D phenotype is reported in a large-scale study. This work is a pioneer in the coordinated optimization of transfusion guidelines at the national level.

**Keywords** ABO, Rh, Blood Group System, Distribution, Indonesia

**Introduction**

Among the 45 blood group systems officially reported to date by the International Society of Blood Transfusion, [1] ABO (ISBT 001) and Rh (ISBT 004) are the most clinically relevant. Indeed, the antibodies directed against these antigens can potentially trigger a hemolytic reaction in patients [2–5]. ABO blood group antibodies may be responsible for severe hemolytic transfusion reactions (HTRs) in patients transfused with incompatible red blood cells (RBCs), [6] while the hemolytic disease of the fetus and newborn (HDFN) due to ABO antibodies, although relatively common, is usually of milder clinical significance. [7, 8] The D antigen harbored by RhD transmembrane protein is the most immunogenic, among Rh antigens. D-positive (D+) RBCs from donors and fetus(s) can elicit alloanti-D production in D-negative (D−)

<footnote>*Correspondence:
Teguh Triyono
teguhpk@ugm.ac.id

¹Biotechnology Study Program, Graduate School, Universitas Gadjah Mada, Yogyakarta, Indonesia</footnote>

<footnote n="2">²Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia</footnote>

<footnote n="3">³Dr Sardjito General Hospital, Yogyakarta, Indonesia</footnote>

<footnote n="4">⁴Univ Brest, Inserm, EFS, UMR1078, GGB, Brest, France</footnote>

<footnote n="5">⁵Laboratory of Excellence GR-Ex, Paris, France</footnote>

<footnote n="6">⁶Laboratory Biochemistry, Faculty of Biology, Universitas Gadjah Mada, Yogyakarta, Indonesia</footnote>

<footnote n="7">⁷Politeknik Kesehatan Bhakti Setya, Yogyakarta, Indonesia</footnote>

<footnote n="8">⁸Indonesian Red Cross, Yogyakarta, Indonesia</footnote>
patients and pregnant women, respectively, a mechanism known as alloimmunization. [9] In alloimmunized patients, a novel exposure to the D antigen may result respectively in HTR and HDFN with a broad range of severity ranging from asymptomatic to fatal outcomes. [2]

In transfusion medicine and obstetrics, prevention of alloimmunization and potential subsequent complications, especially in cases of chronic transfusion, typically relies on blood group typing to ensure compatibility between donors and patients and/or to reinforce monitoring in pregnant women when necessary. [3, 4, 10] Since the discovery of ABO and Rh system, numerous studies available in the literature have reported the distribution of the main antigens, including A, B, and D, in various populations. From these reports, it has long been known that antigen frequency, directly driven by blood group gene polymorphism, varies considerably as a function of the origin of the population of interest. Therefore, knowledge of this distribution can help manage blood banking efficiently at the local, regional, and national levels.

Indonesia is a vast country in Southeast Asia composed of thousands of islands and accounts for the fourth most populous country in the world, with a population estimated to be >280 million inhabitants, including various ethnicities. [11] To our knowledge, blood group antigen frequency in Indonesia is barely available in the literature and remains to be further documented throughout the country. Thus we thought to report for the first time the frequency of ABO and D antigen expression in Yogyakarta, Java Island.

# Main text

## Materials and methods

Blood group records (i.e., ABO/D phenotype) from the blood donors' database of the Yogyakarta Blood Donor Unit between 1st January 2018 and 31st December 2023 were collected retrospectively. Blood donors were selected strictly according to the nationally standardized selection criteria established by the blood bank. Blood sample was taken from male and female volunteer blood donors aged 18–65, weighing more than 45 kg with normal hemoglobin values. Routine ABO and Rh serotyping in donors was performed with automated microplate and microfiltration systems with E.M. Technology (Qwalys 3, Diagast, Loss, France) with the following reagents: ABDLys, Magnelys, Bromeline, Hemalys 1 A1B (Diagast, Loos, France). Manual tube tests were performed with Eryscreen anti-A, anti-B, and anti-D (Tulip Diagnostics, Goa, India). Subgrouping and other blood group antigen tests were not performed. Only donors with concordant forward and reverse typing results were selected for data

analysis. Data were processed using a Microsoft Excel datasheet, and phenotype frequency was calculated.

## Results

Over six years, a total of 245,307 donor blood samples (average: 40,885 donors/year) were analyzed to determine ABO and D blood group antigen distribution. The ABO and D antigen distribution occurred in the following order: O+>B+ > A+>AB+>AB-> O- > A- = B- (38.42% > 29.35% > 24.10% > 7.67% > 0.31% > 0.08% > 0.04% & 0.04%) (Table 1). In the ABO system, the most common phenotype was O (38.5%) followed respectively by B (29.4%), A (24.1%), and AB (8.0%). In the Rh system, the frequency of D+donors is dramatically high (99.5%), while D- donors account for only a minor subset (0.5%) (Table 2).

## Discussion

In this study, the distribution of ABO and Rh blood group systems in donors of a blood bank directory from Yogyakarta, Java Island, was reported retrospectively over six years (2018–2023). To our knowledge, this is the first study conducted on such a large scale in Indonesia.

In this research, the distribution of the ABO blood group phenotype is O>B>A>AB, which is a pattern typically shared by several South East Asian countries, [12–17] and several other countries (Table 2). [18–23] However, variability may be observed between countries. Still, the world distributions occur in the following order: O>A>B>AB [5, 24–30]. The blood group A was more dominant in the Northern Hemisphere. [5] The blood group distribution pattern was complex, clinal, and discontinuous. The distribution pattern can remain constant for several decades, [31] but also can change over time. [32]

The D antigen was found to be carried by the vast majority of donors (Table 2: 99.5%), which is also a general observation in East and Southeast Asia. It is worth mentioning that the D antigen frequency reported here in donors may not reflect precisely the actual distribution in the general population. Indeed, due to a shortage in the availability of D- RBC units in Indonesia, D- donors are encouraged to give their blood regularly. Thus, the frequency of D- individuals may be somewhat overestimated in this study. Next, it will be essential to investigate the nature of D- donors by additional serological and molecular methods to address the potential Asian-type DEL samples in this subset, which have recently been recommended to be considered as D+donors and patients, conversely to the true D- individuals. [33]

Because it is well known that blood group antigen expression varies between populations due to specific genetic variations, knowledge of the distribution of blood groups at a local level/regional/national is critical for
<table><caption>**Table 1** Phenotypic distribution of ABO and D antigens in blood donors from Yogyakarta (Central Java Island, Indonesia) between 2018 and 2023</caption><thead><tr><th rowspan="2">Phenotype</th><th colspan="2">2018</th><th colspan="2">2019</th><th colspan="2">2020</th><th colspan="2">2021</th><th colspan="2">2022</th><th colspan="2">2023</th><th colspan="2">Total</th></tr><tr><th>N</th><th>%</th><th>N</th><th>%</th><th>N</th><th>%</th><th>N</th><th>%</th><th>N</th><th>%</th><th>N</th><th>%</th><th>N</th><th>%</th></tr></thead><tbody><tr><td>O+</td><td>17,589</td><td>38.43</td><td>18,476</td><td>38.65</td><td>13,328</td><td>38.97</td><td>13,097</td><td>38.93</td><td>14,375</td><td>37.97</td><td>17,374</td><td>37.74</td><td>94,239</td><td>38.42</td></tr><tr><td>O-</td><td>26</td><td>0.06</td><td>52</td><td>0.11</td><td>18</td><td>0.05</td><td>26</td><td>0.08</td><td>30</td><td>0.08</td><td>32</td><td>0.07</td><td>184</td><td>0.08</td></tr><tr><td>B+</td><td>13,529</td><td>29.56</td><td>14,054</td><td>29.40</td><td>9,807</td><td>28.68</td><td>9,848</td><td>29.27</td><td>11,137</td><td>29.41</td><td>13,628</td><td>29.60</td><td>72,003</td><td>29.35</td></tr><tr><td>B-</td><td>31</td><td>0.07</td><td>25</td><td>0.05</td><td>12</td><td>0.04</td><td>7</td><td>0.02</td><td>5</td><td>0.01</td><td>11</td><td>0.02</td><td>91</td><td>0.04</td></tr><tr><td>A+</td><td>11,085</td><td>24.22</td><td>11,545</td><td>24.15</td><td>8,288</td><td>24.23</td><td>7,987</td><td>23.74</td><td>9,084</td><td>23.99</td><td>11,123</td><td>24.16</td><td>59,112</td><td>24.10</td></tr><tr><td>A-</td><td>21</td><td>0.05</td><td>38</td><td>0.08</td><td>11</td><td>0.03</td><td>5</td><td>0.01</td><td>17</td><td>0.04</td><td>15</td><td>0.03</td><td>107</td><td>0.04</td></tr><tr><td>AB+</td><td>3,470</td><td>7.58</td><td>3,597</td><td>7.52</td><td>2,716</td><td>7.94</td><td>2,617</td><td>7.78</td><td>2,911</td><td>7.69</td><td>3,503</td><td>7.61</td><td>18,814</td><td>7.67</td></tr><tr><td>AB-</td><td>18</td><td>0.04</td><td>15</td><td>0.03</td><td>19</td><td>0.06</td><td>53</td><td>0.16</td><td>303</td><td>0.80</td><td>349</td><td>0.76</td><td>757</td><td>0.31</td></tr><tr><td>Subtotal/year</td><td>45,769</td><td>100.00</td><td>47,802</td><td>100.00</td><td>34,199</td><td>100.00</td><td>33,640</td><td>100.00</td><td>37,862</td><td>100.00</td><td>46,035</td><td>100.00</td><td>245,307</td><td>100.00</td></tr></tbody></table>

N: number of blood donors

blood banks, transfusion services, and patients' healthcare. This report describing the distribution of ABO and D phenotypes among donors in Indonesia is thought to be a milestone towards the establishment of general guidelines for blood group distribution in the country. Our findings will be helpful to clinicians in their daily practice, planners, and policymakers for optimizing the management of RBC stocks, as well as non-governmental organizations involved in blood supply. This report also has valuable implications for modifying and producing blood products (blood components) to prevent shortages. This finding implies that blood type O is the most available blood group and is more advantageous for the population in transfusion practices. Blood group O, especially O-negative, is crucial to transfusion practice. In Asian countries, including Indonesia (Yogyakarta), the frequency of the O-negative phenotype was lower than in European countries so, the regional bank needs to improve O-negative blood availability to avoid shortages.

[18]

Finally, Indonesia is a large country known for its complex geography and heterogeneity in terms of ethnicity, thus assuming a broad range of genetic backgrounds. While we are currently involved in another comprehensive study nationwide, we encourage other blood banks nationwide to publish their data to increase the amount of data and get a global overview of blood group distribution. Indonesian policymakers need to enhance the standard for blood grouping tests, which include subgrouping and other blood group antigens. While these tests may not be available in regional blood banks, having them accessible in the national blood reference laboratory would be beneficial.

## Limitations

Our study has a few limitations that need to be acknowledged. Our study uses a relatively small sample size compared to the Indonesian population. Due to our testing reagent limitations, there was no subgrouping test for routine serotyping. Serotyping for forward grouping was performed with anti-A, anti-B, and anti-D, and reverse grouping was performed with A1 and B cells. Testing for weak D and H lectins was not performed. Also, in this study, D- donors only donate their blood with a special invitation, so D- distribution may be higher. We are still conducting a more comprehensive nationwide study involving blood donors from different regions and backgrounds in Indonesia to confirm these findings and identify any region-specific variations in the ABO and D antigens among blood donors, considering the country's heterogeneous geography, ethnicity, and genetic variation.
<table><caption>**Table 2** Frequency of ABO and rh D blood groups in Southeast Asia, Asia, and other countries</caption><thead><tr><th rowspan="2">Region/country</th><th colspan="4">ABO (frequency, %)</th><th colspan="2">Rh (frequency, %)</th><th rowspan="2">N</th><th rowspan="2">Reference</th></tr><tr><th>O</th><th>A</th><th>B</th><th>AB</th><th>D+</th><th>D-</th></tr></thead><tbody><tr><td colspan="9"><strong>South East Asia</strong></td></tr><tr><td><strong>Indonesia</strong></td><td><strong>38.5</strong></td><td><strong>24.1</strong></td><td><strong>29.4</strong></td><td><strong>8.0</strong></td><td><strong>99.5</strong></td><td><strong>0.5</strong></td><td><strong>245,307</strong></td><td>This study</td></tr><tr><td>Laos</td><td>37.7</td><td>19.8</td><td>35.6</td><td>6.9</td><td>100.0</td><td>0.0</td><td>464</td><td>16</td></tr><tr><td>Malaysia</td><td>39.2</td><td>24.7</td><td>30.3</td><td>5.8</td><td>99.3</td><td>0.7</td><td>760</td><td>17</td></tr><tr><td>Myanmar</td><td>36.5</td><td>25.2</td><td>33.3</td><td>5.0</td><td>-</td><td>-</td><td>222</td><td>15</td></tr><tr><td>Philippines</td><td>45.4</td><td>24.0</td><td>24.9</td><td>5.7</td><td>98.9</td><td>1.1</td><td>5,953</td><td>12</td></tr><tr><td>Thailand</td><td>37.7</td><td>21.4</td><td>33.6</td><td>7.3</td><td>99.7</td><td>0.3</td><td>1,382,980</td><td>14</td></tr><tr><td>Vietnam</td><td>49.9</td><td>21.8</td><td>25.0</td><td>3.3</td><td>100.0</td><td>0.0</td><td>423</td><td>13</td></tr><tr><td colspan="9"><strong>Asia</strong></td></tr><tr><td>India</td><td>37.12</td><td>22.88</td><td>32.26</td><td>7.74</td><td>94.61</td><td>5.39</td><td>9,686</td><td>19</td></tr><tr><td>Pakistan-North_Western</td><td>28.79</td><td>28.16</td><td>32.34</td><td>10.71</td><td>90.72</td><td>9.28</td><td>226,963</td><td>21</td></tr><tr><td>Pakistan-Faisalabad</td><td>32.78</td><td>22.58</td><td>29.79</td><td>14.83</td><td>81.01</td><td>18.99</td><td>17,205</td><td>20</td></tr><tr><td>Pakistan-Safdarabad</td><td>33.74</td><td>25.28</td><td>33.81</td><td>7.15</td><td>90.00</td><td>10.00</td><td>13,477</td><td>20</td></tr><tr><td>China</td><td>34.20</td><td>28.72</td><td>28.17</td><td>8.91</td><td>-</td><td>-</td><td>23,697,367</td><td>29</td></tr><tr><td>Japan</td><td>29.25</td><td>38.65</td><td>22.15</td><td>9.95</td><td>-</td><td>-</td><td>4,464,349</td><td>28</td></tr><tr><td colspan="9"><strong>Others</strong></td></tr><tr><td>Australia-nonAborigin</td><td>45.2</td><td>37.1</td><td>13.0</td><td>4.7</td><td>83.7</td><td>16.3</td><td>2,657</td><td>30</td></tr><tr><td>Australia-Aborigin</td><td>56.6</td><td>39.7</td><td>2.9</td><td>0.8</td><td>97.6</td><td>2.4</td><td>1,686</td><td>30</td></tr><tr><td>Antananarivo</td><td>41.60</td><td>22.61</td><td>29.66</td><td>6.13</td><td>98.9</td><td>1.1</td><td>45,857</td><td>23</td></tr><tr><td>Burkina Faso</td><td>43.30</td><td>22.54</td><td>28.56</td><td>5.60</td><td>92.24</td><td>7.76</td><td>81,486</td><td>18</td></tr><tr><td>Germany-SouthWestern</td><td>41.21</td><td>43.26</td><td>10.71</td><td>4.82</td><td>-</td><td>-</td><td>62,161</td><td>26</td></tr><tr><td>Guinea</td><td>48.88</td><td>22.54</td><td>23.86</td><td>4.72</td><td>95.94</td><td>4.06</td><td>59,452</td><td>22</td></tr><tr><td>Mexico</td><td>61.82</td><td>27.44</td><td>8.93</td><td>1.81</td><td>95.58</td><td>4.42</td><td>271,164</td><td>27</td></tr><tr><td>Uganda</td><td>50.3</td><td>24.6</td><td>20.7</td><td>4.5</td><td>97.97</td><td>2.03</td><td>23,504</td><td>25</td></tr><tr><td>United States</td><td>46.6</td><td>37.1</td><td>12.2</td><td>4.1</td><td>85.4</td><td>14.6</td><td>3,086,215</td><td>24</td></tr></tbody></table>

N: number of individuals analysed in the respective studies; -: not reported

**Acknowledgements**

The authors wish to thank all blood donors in the Yogyakarta Blood Transfusion Unit. The authors acknowledge Mr Didik and Mrs. Wiwin for preparing blood donor database data in this manuscript.

**Author contributions**

Hasna Fadlilatul Bidayah, Teguh Triyono, Rarastoeti Pratiwi, and Abdul Salam Sofro designed the study. Hasna Fadlilatul Bidayah and Diah Nur Pratami collected and entered data into a data sheet. Hasna Fadlilatul Bidayah and Yann Fichou performed the data analysis and wrote the manuscript. Teguh Triyono was funding this research. All authors read, reviewed, and approved the manuscript.

**Funding**

Financial support was given for this study from Kementrian Riset Teknologi dan Pendidikan Tinggi, Republik Indonesia, with grant number 098/E5/ PG.02.00.PL/2023;2454/UN1/DITLIT/DitLit/PT.01.03/2023.

**Data availability**

The datasets used during the current study are available from the corresponding author upon reasonable request.

**Declarations**

**Ethics approval**

All the procedures were reviewed and approved by the Medical and Health Study Ethics Committee, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada-Dr. Sardjito General Hospital, with approval number KE/FK/1228/EC/2020. Official permission was also obtained from the Yogyakarta Blood Donor Unit.

**Consent to participate**

Donors provide a written statement (Donor statement) before the donor donates their blood at Yogyakarta Blood Donor Unit.

**Consent for publication**

Not applicable.

**Competing interests**

The authors declare no competing interests.

Received: 1 March 2024 / Accepted: 27 August 2024

Published online: 18 September 2024

**References**

1. ISBT. Red Cell Immunogenetics and Blood Group Terminology. Red Cell Immunogenetics and Blood Group Terminology. https://www.isbtweb.org/ working-parties/red-cell-immunogenetics-and-blood-group-terminology/.

2. Daniels G. Human blood groups. 3rd ed. Wiley-Blackwell; 2013.

3. Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev. 2007;21(1):58-71. https://doi.org/10.1016/j. tmrv.2006.08.003.

4. Daniels G, Poole J, De Silva M, Callaghan T, MacLennan S, Smith N. The clinical significance of blood group antibodies. Transfus Med. 2002;12(5):287-95. https://doi.org/10.1046/j.1365-3148.2002.00399.x.

5. Dean L. Blood groups and red cell antigens. National Center for Biotechnology Information; 2005.

6. Janatpour KA, Kalmin ND, Jensen HM, Holland PV. Clinical outcomes of ABO-Incompatible RBC transfusions. Am J Clin Pathol. 2008;129(2):276-81. https:// doi.org/10.1309/VXY1ULAFUY6E6JT3.
7. Matteocci A, De Rosa A, Buffone E, Pierelli L. Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 years. Transfus Med. 2019;29(3):197-201. https://doi.org/10.1111/tme.12512.

8. Yu D, Ling LE, Krumme AA, Tjoa ML, Moise KJ. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010. AJOG Global Rep. 2023;3(2):100203. https://doi.org/10.1016/j.xagr.2023.100203.

9. Levine P, Burnham L, Katzin EM, Vogel P. The role of iso-immunization in the pathogenesis of erythroblastosis fetalis. Am J Obstet Gynecol. 1941;42(6):925-37. https://doi.org/10.1016/S0002-9378(41)90260-0.

10. Hendrickson JE, Tormey CA, Shaz BH. Red blood cell alloimmunization mitigation strategies. Transfus Med Rev. 2014;28(3):137-44. https://doi.org/10.1016/j.tmrv.2014.04.008.

11. BPS. Badan Pusat Statistik Jumlah Penduduk Pertengahan Tahun (Ribu Jiwa), 2022-2024. https://www.bps.go.id/id/statistics-table/2/MTk3NSMy/jumlah-penduduk-pertengahan-tahun-ribu-jiwa.html

12. Cabo CC, Yap-Dejeto LG. Frequency distribution of ABO and Rhesus (D) blood groups in Tacloban City, Philippines (2014-2015). Phil J Nat Sci. 2020;25:41-58.

13. Todorov V, Boycheva M, Minkov C, Georgiev V, Boichev M. Blood group ABO and Rhesus factor systems distribution in individuals of Vietnamese nationality. J Sci Appl Res. 2017;12:74-8.

14. Fongsarun J, Nuchprayoon I, Yod-In S, Kupatawintu P, Kidprasirt C. Blood groups in Thai blood donors. Thai J Hematol Transfus Med. 2002;12(4):277-86.

15. Wah ST, Chi SN, Kyaing KK, Khin AA, Aung T. Serological detection of Rh-Del phenotype among Rh-Negative blood donors at National Blood Center, Yangon, Myanmar. Adv Hematol. 2020;2020:1-5. https://doi.org/10.1155/2020/3482124.

16. Keokhamphoui C, Urwijitaroon Y, Kongphaly D, Thammavong T. Blood group antigen distribution in Lao blood donors. Immunohematology. 2012;28(4):132-6.

17. Yousuf R, Abdul Ghani SA, Abdul Khalid N, Leong CF. Study on ABO and RhD blood grouping: comparison between conventional tile method and a new solid phase method (InTec Blood Grouping Test Kit). Malays J Pathol. 2018;40(1):27-32.

18. Sawadogo S, Nebie K, Millogo T, et al. Distribution of ABO and RHD blood group antigens in blood donors in Burkina Faso. Int J Immunogenet. 2019;46(1):1-6. https://doi.org/10.1111/iji.12408.

19. Agrawal A, Tiwari A, Mehta N, et al. ABO and rh (D) group distribution and gene frequency; the first multicentric study in India. Asian J Transfus Sci. 2014;8(2):121. https://doi.org/10.4103/0973-6247.137452.

20. Sabir A, Iftikhar A, Ijaz MU, et al. Retrospective study of frequency of ABO and Rhesus blood group among population of Safdarabad and Faisalabad cities of Pakistan. BMC Res Notes. 2021;14(1):12. https://doi.org/10.1186/s13104-020-05429-z.

21. Rehman AU, Anwar I, Rashid A, Malik S. Frequencies of ABO and rh (D) blood Group Phenotypes in pashtuns of North-Western Pakistan: a population undergoing huge demographic changes. Int J Immunogenet. 2021;48(4):336-9. https://doi.org/10.1111/iji.12536.

22. Loua A, Lamah MR, Haba NY, Camara M. Fréquence Des groupes sanguins ABO et rhésus D dans la population guinéenne. Transfus Clin Biol. 2007;14(5):435-9. https://doi.org/10.1016/j.tracli.2007.12.008.

23. Randriamanantany ZA, Rajaonatahina DH, Razafimanantsoa FE, et al. Phenotypic and allelic profile of ABO and Rhésus D blood group system among blood donor in Antananarivo. Int J Immunogenet. 2012;39(6):477-9. https://doi.org/10.1111/j.1744-313X.2012.01120.x.

24. Garratty G, Glynn SA, McEntire R. ABO and rh(D) phenotype frequencies of different racial/ ethnic groups in the United States. Transfus (Paris). 2004;44(5):703-6. https://doi.org/10.1111/j.1537-2995.2004.03338.x.

25. Apecu RO, Mulogo EM, Bagenda F, Byamungu A. ABO and Rhesus (D) blood group distribution among blood donors in rural south western Uganda: a retrospective study. BMC Res Notes. 2016;9(1):513. https://doi.org/10.1186/s13104-016-2299-5.

26. Wagner FF, Kasulke D, Kerowgan M, Flegel WA. Frequencies of the Blood Groups ABO, Rhesus D, Category VI. Kell, and of Clinically Relevant High-Frequency Antigens in South-Western Germany. Transfusion Medicine and Hemotherapy. 1995;22(5):285-290. https://doi.org/10.1159/000223144

27. Canizalez-Román A, Campos-Romero A, Castro-Sánchez JA, et al. Blood groups distribution and gene diversity of the ABO and rh (D) loci in the Mexican Population. Biomed Res Int. 2018;2018:1-11. https://doi.org/10.1155/2018/1925619.

28. Fujita Y, Tanimura M, Tanaka K. The distribution of the ABO blood groups in Japan. Jinrui Idengaku Zasshi. 1978;23(2):63-109. https://doi.org/10.1007/BF02001790.

29. Sun Y, Wang L, Niu J, et al. Distribution characteristics of ABO blood groups in China. Heliyon. 2022;8(9):e10568. https://doi.org/10.1016/j.heliyon.2022.e10568.

30. McLean A, Szabo F, Wang Z. <scp> ABO and Rhesus D blood groups in the Northern Territory of Australia</scp>. Intern Med J. 2021;51(9):1485-9. https://doi.org/10.1111/imj.15199.

31. Volken T, Crawford RJ, Amar S, Mosimann E, Tschaggelar A, Mansouri Taleghani B. Blood group distribution in Switzerland - a historical comparison. Transfus Med Hemotherapy. 2017;44(4):210-6. https://doi.org/10.1159/000479191.

32. Lialiaris T, Digkas E, Kareli D, et al. Distribution of ABO and rh blood groups in Greece: an update. Int J Immunogenet. 2011;38(1):1-5. https://doi.org/10.1111/j.1744-313X.2010.00958.x.

33. Ji Y, Luo Y, Wen J, et al. Patients with asian-type DEL can safely be transfused using RhD-positive blood. Blood Published Online January. 2023;13. https://doi.org/10.1182/blood.2022018152.

## Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.